Working Toward A Cure: Janssen’s Multiple Myeloma Strategy

T-cell Engagers, CAR-T Therapy Build On Darzalex Success

 
• By Mandy Jackson
  
Multiple myeloma concept on tablet screen with stethoscope
Janssen will build on its Darzalex franchise with CAR-T therapies, bispecifics and more • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D